Skip to main content
Year archive

AstraZeneca Pharma India Ltd. — 2019 filings

All 86 regulatory filings released by AstraZeneca Pharma India Ltd. (ASTRAZEN) in 2019, sourced directly from the official regulator.

86 Filings
2019 Period
2019 filings (86)
Filing Released Lang
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform that an interaction with analysts / investors is scheduled to ....
Regulatory Filings
2019-12-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-12-13 English
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that a one-on-one meeting is scheduled to be held with following ....
Regulatory Filings
2019-12-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2019-12-04 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-12-04 English
Related Party Transactions
Regulatory Filings
2019-11-27 English
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party ....
Regulatory Filings
2019-11-27 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-11-19 English
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on November 13, ....
Regulatory Filings
2019-11-14 English
Updates
Regulatory Filings
2019-11-14 English
Reappointment
Board/Management Information
2019-11-12 English
The Board of Directors of the Company, on the recommendation of the Nomination and Remuneration Committee has approved the re-appointment of Mr. Rajesh Marwaha (DIN ....
Board/Management Information
2019-11-12 English
Financial Result Updates
Regulatory Filings
2019-11-11 English
At the Board meeting of the Company held on Monday, November 11, 2019 the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended ....
Interim / Quarterly Report
2019-11-11 English
Updates
Regulatory Filings
2019-10-30 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform that Ms. Revathy Ashok (DIN: 00057539), Non-Executive Independent ....
Regulatory Filings
2019-10-30 English
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on October 25, ....
Regulatory Filings
2019-10-25 English
Updates
Regulatory Filings
2019-10-25 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve the Unaudited Financial ....
Regulatory Filings
2019-10-24 English
Board Meeting — Financial Results
Regulatory Filings
2019-10-24 English
As required under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith a Certificate issued by the Practicing Company Secretary ....
Regulatory Filings
2019-10-23 English
We refer to our communication dated June 21, 2018 with regard to the receipt of Import and Market Permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India ....
Regulatory Filings
2019-10-21 English
Updates
Regulatory Filings
2019-10-21 English
This is to certify that, Integrated Registry Management Services Private Limited are the Company's Registrar and Transfer Agents and that all activities in relation to the share transfer ....
Regulatory Filings
2019-10-15 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-10-15 English
This is to inform that AstraZeneca Pharma India Limited has received Import and Market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for FDC ....
Regulatory Filings
2019-09-25 English
Updates
Regulatory Filings
2019-09-25 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-08-14 English
Updates
Regulatory Filings
2019-08-09 English
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on August 9, 2019 ....
Earnings Release
2019-08-09 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-08-09 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2019-08-09 English
We wish to inform you that at the Company's Annual General Meeting held on August 7, 2019, the Shareholders have approved the appointment of Mr. Narayan K Seshadri (DIN: 00053563) as Independent ....
Board/Management Information
2019-08-08 English
Reappointment
Board/Management Information
2019-08-08 English
In relation to the 40th Annual General Meeting of the Company held on August 7, 2019, we enclose the report of Scrutinizer dated August 8, 2019, as required Section 108 of the Companies ....
Declaration of Voting Results & Voting Rights Announcements
2019-08-08 English
In relation to the 40th Annual General Meeting of the Company held on August 7, 2019, we enclose the brief proceedings as required under Regulation 30, Part A of Schedule III of the SEBI ....
Regulatory Filings
2019-08-08 English
Shareholders meeting
AGM Information
2019-08-08 English
AstraZeneca Pharma India Ltd has informed BSE that the Company has fixed August 21, 2019 as the Record Date for the purpose of Payment of Interim Dividend.
Interim / Quarterly Report
2019-08-08 English
Date of payment of dividend
Notice of Dividend Amount
2019-08-07 English
We would wish to inform that at the Board Meeting of the Company held today i.e., on August 7, 2019, the Board of Directors have inter-alia declared an Interim Dividend of Rs. 1.00 per ....
Notice of Dividend Amount
2019-08-07 English
Record Date
Interim / Quarterly Report
2019-08-07 English
Dividend
Interim / Quarterly Report
2019-08-07 English
AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at their meeting held on August 07, 2019, inter alia, has declared Interim Dividend of Rs. 1 (One) ....
Interim / Quarterly Report
2019-08-07 English
The Board of Directors of the Company at their meeting held today i.e, August 7, 2019, has inter-alia: 1. Approved the Unaudited Financial Results of the Company for the quarter ....
Interim / Quarterly Report
2019-08-07 English
Financial Result Updates
Regulatory Filings
2019-08-07 English
Updates
Regulatory Filings
2019-08-01 English
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on August 1, 2019 ....
Regulatory Filings
2019-08-01 English
AstraZeneca Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 07, 2019, inter alia, to:1. consider and approve the ....
Capital/Financing Update
2019-07-29 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2019 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2019-07-29 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2019-07-29 English
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting with investors/analysts is scheduled to be ....
Regulatory Filings
2019-07-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-07-22 English
Please find enclosed copies of the newspaper cuttings published in leading English newspaper (Business Standard) and in Regional language newspaper (Udayavani) on July 15, 2019 in respect ....
Regulatory Filings
2019-07-15 English
Updates
AGM Information
2019-07-15 English
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Report of the Company for the financial ....
Regulatory Filings
2019-07-11 English
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of the 40th Annual General ....
Regulatory Filings
2019-07-11 English
Shareholders meeting
AGM Information
2019-07-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-07-05 English
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that a one-on-one meeting with Finvest Advisors is scheduled ....
Regulatory Filings
2019-07-05 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-06-26 English
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party ....
Regulatory Filings
2019-06-14 English
Related Party Transactions
Interim / Quarterly Report
2019-06-13 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-06-07 English
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period ....
Regulatory Filings
2019-05-29 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-05-29 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-05-27 English
The Securities and Exchange Board of India has introduced the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2018. In tune with ....
Regulatory Filings
2019-05-24 English
Updates
Regulatory Filings
2019-05-24 English
The Board of Directors of the Company, on the recommendation of the Nomination and Remuneration Committee and subject to approval by the shareholders, has re-appointed Mr. Narayan K Seshadri, ....
Regulatory Filings
2019-05-24 English
Updates
Regulatory Filings
2019-05-24 English
At the Board Meeting of the Company held on Friday, May 24, 2019 the Board of Directors considered and approved the Audited Financial Results of the Company for the quarter and year ended ....
Regulatory Filings
2019-05-24 English
Financial Result Updates
Regulatory Filings
2019-05-24 English
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2019 ,inter alia, to consider and approve This is to inform ....
Regulatory Filings
2019-05-16 English
Board Meeting — Financial Results
Regulatory Filings
2019-05-16 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2019-04-30 English
As required under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith a Certificate issued by the Practicing Company Secretary ....
Regulatory Filings
2019-04-29 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate ....
Regulatory Filings
2019-04-26 English
This is to certify that, Integrated Registry Management Services Private Limited are the Company's Registrar and Transfer Agents and that all activities in relation to both the physical ....
Regulatory Filings
2019-04-12 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification
2019-04-11 English
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received for Loss of share certificate and issue of duplicate share certificate in respect ....
Regulatory Filings
2019-03-20 English
This is to inform you that on March 13, 2019, the Board of the Directors of the Company has appointed Ms. Weiying Sarah Wang (DIN: 08369289) as an Additional Director (Non-Executive) on ....
Regulatory Filings
2019-03-14 English
Appointment
Regulatory Filings
2019-03-14 English
Spurt in Volume
Regulatory Filings
2019-02-08 English
Resignation
Regulatory Filings
2019-02-06 English
Financial Result Updates
Regulatory Filings
2019-02-06 English
Board Meeting — Financial Results
Regulatory Filings
2019-01-24 English